We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Source of Very Cold Electrons Designed to Improve Quality, Speed of Nanoimaging for Drug and Materials Development

By LabMedica International staff writers
Posted on 18 Aug 2011
Australian scientists reported that a new cold electron source offers potential advances in electron imaging at the atomic or nanoscale that should have real applications in a range of industries including health.

The study’s findings were published online July 31, 2011, in the journal Nature Physics. More...
Associate Prof. Robert Scholten from School of Physics at the University of Melbourne (Australia) and the University’s ARC Center of Excellence for Coherent X-ray Science (CXS), said, “Enhanced nanoimaging using this cold source will enable us to design better drugs for more targeted treatments. Having a better visibility of the structure of a cell membrane protein, and how it functions will assist in more targeted drug design. It will also help us understand how vulnerabilities such as cracks form, when designing new materials for advanced technology such as in turbine blades for jet engines. Nano imaging using electron microscopy give us intricate images of the micro and nanoscale world, but conventional hot electron sources are incoherent-like the indirect light of light bulbs versus direct laser beams. Depending on the target, it can take several minutes to several hours to undergo this process and the image is not very clear. Our experiments have revealed that with cold electrons and our new technology, we will be able to take a snapshot of the whole sample with atomic resolution and to reduce the imaging time to a trillionth of a second,” he said.

The team, led by Assoc. Prof. Scholten, used lasers to cool atoms to a few millionths of a degree above absolute zero and then to extract a beam of extremely cold electrons. Using new technology, they were able to create beams in complex shapes, and because the electrons are so very cold (about 10 K) the beam retains that shape, rather than exploding as it would for a conventional hot electron source. “This new cold source will allow us to see dynamic processes within the sample, to understand how it functions on a more precise level,” he said. “Cold electron technology opens up a whole new world of imaging--this study is the first to show its real potential.”

The researchers envision that the technology will be further developed in the next few years.

Related Links:

University of Melbourne ARC Center of Excellence for Coherent X-ray Science




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.